| Title : The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion - El-Ouaghlidi_2007_J.Clin.Endocrinol.Metab_92_4165 |
| Author(s) : El-Ouaghlidi A , Rehring E , Holst JJ , Schweizer A , Foley J , Holmes D , Nauck MA |
| Ref : J Clinical Endocrinology Metab , 92 :4165 , 2007 |
| Abstract : El-Ouaghlidi_2007_J.Clin.Endocrinol.Metab_92_4165 |
| ESTHER : El-Ouaghlidi_2007_J.Clin.Endocrinol.Metab_92_4165 |
| PubMedSearch : El-Ouaghlidi_2007_J.Clin.Endocrinol.Metab_92_4165 |
| PubMedID: 17698900 |
El-Ouaghlidi A, Rehring E, Holst JJ, Schweizer A, Foley J, Holmes D, Nauck MA (2007)
The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion
J Clinical Endocrinology Metab
92 :4165
El-Ouaghlidi A, Rehring E, Holst JJ, Schweizer A, Foley J, Holmes D, Nauck MA (2007)
J Clinical Endocrinology Metab
92 :4165